Logo: to the web site of Uppsala University

Randomized phase II marker lesion study evaluating effect of scheduling on response to intravesical gemcitabine in recurrent Stage Ta urothelial cell carcinoma of the bladder. 2005 (English)In: Urology, ISSN 1527-9995, Vol. 66, no 3, p. 527-30Article in journal (Refereed) Published

Place, publisher, year, edition, pages

2005. Vol. 66, no 3, p. 527-30

Keywords [en]

Administration; Intravesical, Aged, Aged; 80 and over, Antimetabolites; Antineoplastic/*administration & dosage, Bladder Neoplasms/*drug therapy/pathology, Carcinoma; Transitional Cell/*drug therapy/pathology, Deoxycytidine/administration & dosage/*analogs & derivatives, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Neoplasm Recurrence; Local/*drug therapy, Neoplasm Staging, Research Support; Non-U.S. Gov't

Identifiers

URN: urn:nbn:se:uu:diva-80579PubMedID: 16140071OAI: oai:DiVA.org:uu-80579DiVA, id: diva2:108493

Available from: 2006-05-18 Created: 2006-05-18 Last updated: 2011-01-11

Open Access in DiVA

No full text in DiVA

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=16140071&dopt=Citation

Authority records

Gårdmark, TrulsMalmström, Per-Uno

Search in DiVA

By author/editor

Gårdmark, TrulsMalmström, Per-Uno

By organisation

Department of Surgical Sciences

Search outside of DiVA

GoogleGoogle ScholarTotal: 504 hits